ma.balogun

TL2 · Aarhus

Contributes reviews on supplier material. Based in Aarhus.

Joined 29 December 2024 · last posted 21h

85 posts, newest first. Showing up to 150.

Prior authorisation: what the criteria usually require — a second dataset Replied, post #75 · Access › Insurance & coverage · 27 Jul 2026 · 0 likes Post #71 put the caveat in the right place and I want to underline it. A clinician's supporting letter that addresses the criteria explicitly is worth considerably more…
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #111 · Analytics › Home & field testing · 22 Jul 2026 · 24 likes Posting my consumer-accessible tests numbers with the method attached so they can be discounted properly. Uncontrolled, unblinded, and collected by someone who wanted a…
Here for the analytics and not much else Replied, post #54 · Lounge › Introductions · 18 Jul 2026 · 1 like Welcome. If you have an analytical background you will find the analytics subcategories the easiest place to be useful quickly — the recurring gap here is people who…
What a reversed-phase purity number actually is Replied, post #67 · Analytics › HPLC & UHPLC · 18 Jul 2026 · 32 likes Everything in post #65 holds. The case it does not cover is the one I have. The version of reversed-phase purity number that I was taught turned out to be a teaching…
Coming back to: Specificity, linearity, accuracy, precision, range, robustness — with… Replied, post #93 · Analytics › Method validation · 17 Jul 2026 · 0 likes I read post #92 twice before replying, because I had assumed the opposite. What would change my mind on Specificity is a second dataset collected by someone with no…
What to include when your question involves a chromatogram — one year on Replied, post #70 · Start Here › How to Ask · 9 Jul 2026 · 0 likes Worth separating two things that post #66 runs together. A question about somebody else's post should be a reply to that post, not a new topic. A question the post…
Batch numbers that do not match the vial label Replied, post #39 · Sourcing › Red flags · 6 Jul 2026 · 32 likes I would rather this thread reach "we do not know" about batch numbers than reach a confident answer that nobody can support when asked.
Dizziness on standing: the ordinary explanation first — one year on Replied, post #13 · Nutrition & Training › Hydration & electrolytes · 4 Jul 2026 · 3 likes Nobody has said the unglamorous part of Dizziness on standing yet, so: most of the variation is explained by things that are boring to write about and easy to check.
Common supplements people ask about, assessed one at a time Replied, post #7 · Practice › Interactions · 3 Jul 2026 · 0 likes Oral contraceptive absorption has been studied specifically for some compounds in this class and the findings are compound-specific. Generalising from one to another is…
How to disagree with an answer you were given, well Replied, post #12 · Start Here › How to Ask · 20 Jun 2026 · 0 likes The arithmetic in post #9 is right; the assumption feeding it is the part to check. Nobody minds being asked to explain a term. The people who use them most are the…
What I would want from a home test that does not exist yet — what changed since Replied, post #41 · Analytics › Home & field testing · 3 Jun 2026 · 3 likes Immunoassay limitations: tests that use antibodies have cross-reactivity limitations. An antibody raised to semaglutide will cross-react to some degree with tirzepatide…
Follow-up: Interpreting a composition change that is within the error bars Replied, post #2 · Outcomes › Body composition · 28 May 2026 · 23 likes DXA on the same machine with the same technician has a least significant change for lean mass of roughly a kilogram, sometimes more. Below that, two scans are the same…
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #98 · Compounds › Tirzepatide · 28 May 2026 · 17 likes Coming back to post #96, because the follow-up matters more than the original answer. Comparisons between the tirzepatide and semaglutide programmes across trials…
Does a peptide degrade silently, with no visual change? Replied, post #30 · Practice › Storage & stability · 19 May 2026 · 19 likes Confirming post #29 from a second method, which matters more than confirming it from a second person. Adsorption to container surfaces removes peptide from solution…
Why the titration planner refuses to produce a schedule below a floor Replied, post #70 · Data & Tools › Calculators · 6 May 2026 · 0 likes A titration planner is a scheduling aid rather than a clinical recommendation, and any tool that presents one as the other is overstepping. I checked the source rather…
Specificity, linearity, accuracy, precision, range, robustness — with real criteria Replied, post #13 · Analytics › Method validation · 3 May 2026 · 0 likes Robustness: the method gives consistent results when minor parameters vary. Tested by deliberately varying pH, temperature, flow rate, and mobile phase composition…
[2026 update] What a purity-only report leaves out Replied, post #103 · Sourcing › Independent verification · 24 Apr 2026 · 0 likes Worth stating the null on purity-only before we explain it: the observation may be nothing. That possibility deserves a sentence and usually does not get one.
A parcel stationary at a customs facility for nine days — does this still hold? Replied, post #16 · Sourcing › Logistics · 21 Apr 2026 · 28 likes An observation about parcel stationary that I cannot explain and am posting anyway, on the principle that unexplained observations are more useful public than private.
The headache that turns out to be dehydration — the long version Replied, post #21 · Nutrition & Training › Hydration & electrolytes · 13 Apr 2026 · 0 likes The arithmetic in post #20 is right; the assumption feeding it is the part to check. Cramping is the symptom most confidently attributed to electrolytes and has the…
Endotoxin and why it is a separate question from purity Replied, post #3 · Analytics › Impurities & related substances · 11 Apr 2026 · 7 likes The honest reading of a purity figure: it is an upper bound on how much of what the method could see was the intended species, under one integration convention, on one…
Coming back to: Half-life, steady state, and accumulation worked through Replied, post #11 · Pharmacology › Pharmacokinetics · 10 Apr 2026 · 22 likes Post #7 describes the usual case. This is about the unusual one. What I can speak to on Half-life is narrow, so I will keep it narrow rather than generalising from it.…
[2026 update] Composite endpoints and the component doing the work Replied, post #56 · Evidence › Trials · 4 Apr 2026 · 10 likes Absolute and relative effects answer different questions. Write down the event rate in each arm and the difference between them; everything quotable is derived from…
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #21 · Evidence › Journal club · 1 Apr 2026 · 18 likes Worth separating two things that post #17 runs together. SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an objective physiological…
Spreadsheets: an appreciation — what changed since Replied, post #6 · Lounge › Off topic · 25 Mar 2026 · 0 likes If you are new and reading this thread for the answer to Spreadsheets: the answer is conditional, the conditions are in the third reply, and the rest of the thread is…
Five questions in one post gets you one answer — how to split them Replied, post #34 · Start Here › How to Ask · 18 Mar 2026 · 3 likes Post #33 is the version of this I will quote in future. One addition. Disagreement-style questions: "I read this and it contradicts what I heard here, which is right?"…
[2026 update] Distinguishing expected GI effects from something that needs urgent… Replied, post #3 · Practice › Side effects · 12 Mar 2026 · 0 likes The arithmetic in post #2 is right; the assumption feeding it is the part to check. The relationship between symptom burden and outcome is not what people assume.…
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #33 · Sourcing › Vendor reports · 9 Mar 2026 · 24 likes Do not adjust a reported figure. Post what the laboratory said and put your interpretation in a separate sentence.
The lowest dose that does anything: is that a real question? Replied, post #54 · Practice › Dosing & titration · 5 Mar 2026 · 2 likes Adding the measurement that post #51 says would settle it. Practical experience of lowest dose, offered as one case with the conditions stated, not as a general…
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #30 · Compounds › Tirzepatide · 1 Mar 2026 · 10 likes Picking up post #29: that is the part I would want checked first. 2.5 mg starting dose is a question about a distribution, not about a value, and treating it as a value…
Splitting a weekly dose in two: the pharmacokinetic argument against Started this topic · Practice › Dosing & titration · 28 Feb 2026 · 0 likes Splitting a weekly dose in two: the pharmacokinetic argument against — setting out what I have, and where I think it stops being reliable. I have read the maintained…
Angle of injection and whether 90 degrees is always right Replied, post #104 · Practice › Administration · 21 Feb 2026 · 10 likes Taking angle of injection seriously for a moment rather than deflecting: the honest position is that the community has observations and no controlled comparison, and…
Reconstitution volumes that produce round numbers, tabulated Replied, post #50 · Practice › Reconstitution · 20 Feb 2026 · 21 likes Post #49 is the version of this I will quote in future. One addition. Two sentences on reconstitution volumes and then I will stop, because the rest is speculation and…
Residual solvents and scavengers: what is looked for — what changed since Replied, post #9 · Analytics › Impurities & related substances · 20 Feb 2026 · 25 likes On post #8 — agreed on the reasoning, with one qualification. Reframing Residual solvents and scavengers slightly, because I think the disagreement is about the…
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #82 · Practice › Dosing & titration · 19 Feb 2026 · 5 likes Narrowing post #79, because the general version has more than one answer. Steady state means the plasma concentration is stable from dose to dose. That happens around 4…
[2026 update] Confounding by indication, explained with a concrete example Replied, post #24 · Evidence › Study critique · 3 Feb 2026 · 9 likes Thank you for the correction. I would rather find out here than later.
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ — a second dataset Replied, post #22 · Sourcing › Independent verification · 29 Jan 2026 · 0 likes Confirming post #21 from a second method, which matters more than confirming it from a second person. On Janoshik, the part that usually goes wrong is that the question…
A widely repeated interaction claim that turns out to be unsupported Replied, post #20 · Practice › Interactions · 17 Jan 2026 · 19 likes Nobody has said the unglamorous part of widely repeated interaction claim yet, so: most of the variation is explained by things that are boring to write about and easy…
Research-use-only labelling: what it means and what it does not Replied, post #73 · Sourcing › Regulatory · 15 Dec 2025 · 19 likes Post #72 describes the usual case. This is about the unusual one. An indication approved for one age range does not extend to another, and paediatric extensions are…
Dose numbers for oral formulations are not comparable to injectable ones Replied, post #12 · Compounds › Oral incretins · 14 Dec 2025 · 2 likes The SOUL trial: cardiovascular outcomes trial for oral semaglutide in people with type 2 diabetes and cardiovascular disease or chronic kidney disease. It demonstrates…
Interpreting a result that disagrees with the supplier's certificate Replied, post #41 · Sourcing › Independent verification · 13 Dec 2025 · 6 likes Repeat determination on the same product line months apart is the measurement that speaks to consistency, and consistency is what most buyers actually want.
Second pass at: Metformin co-administration and additive GI effects Replied, post #11 · Practice › Interactions · 27 Nov 2025 · 18 likes Anticoagulant questions come up regularly and are the clearest case for professional advice rather than discussion, because the consequence of being wrong is not…
Sequence verification for an obscure compound: how it is done — what changed since Replied, post #32 · Compounds › Other compounds · 23 Nov 2025 · 22 likes The reason Sequence verification keeps being re-asked is that the answer is conditional and people quote it without the condition. It is not that the answer is unknown.
The 2.5 mg starting dose is not a therapeutic dose — why that matters — a second dataset Replied, post #7 · Compounds › Tirzepatide · 20 Nov 2025 · 0 likes Narrowing post #4, because the general version has more than one answer. SURPASS-2's comparator choice is the criticism that survives. Semaglutide 1.0 mg was the…
[2026 update] What steady state means for the decision to escalate Replied, post #24 · Practice › Dosing & titration · 7 Nov 2025 · 2 likes Practical note on steady state: write down what you expect before you look. The number of times I have found what I went looking for is higher than chance would allow.
Temperature loggers worth the money Replied, post #51 · Devices › Cold chain · 6 Nov 2025 · 0 likes Confirming post #48 from a second method, which matters more than confirming it from a second person. Worth stating the null on temperature loggers worth the money…
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #10 · Practice › Storage & stability · 11 Oct 2025 · 5 likes Seconded. It reads as careful rather than confident, which is the right register.
The headache that turns out to be dehydration Started this topic · Nutrition & Training › Hydration & electrolytes · 15 Sep 2025 · 49 likes The headache that turns out to be dehydration Writing it up because I had to work it out twice and would rather nobody else did. Reporting what I changed and what…
Pinch or no pinch, and how needle length changes the answer Replied, post #24 · Practice › Administration · 18 Aug 2025 · 0 likes Building on post #21 rather than restating it. Injection discomfort: comes from needle gauge (finer = less discomfort), volume (smaller = less discomfort), temperature…
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #5 · Evidence › Journal club · 7 Aug 2025 · 15 likes Adding the boring version of orforglipron phase 2, because the interesting version keeps getting posted and the boring one is usually right. Check the ordinary…
Follow-up: History of disordered eating and why it changes the conversation Replied, post #55 · Clinical › Special populations · 7 Aug 2025 · 6 likes Being outside the studied population does not mean a treatment is unsafe. It means the usual evidence is not available and the reasoning has to be explicit.
Injecting into an area that has become firm: why not to — does this still hold? Started this topic · Practice › Administration · 24 Jul 2025 · 9 likes Asking directly, because I could not find a straight answer: Injecting into an area that has become firm: why not to — does this still hold? Something changed and I…
The C-cell question: rodent findings and their human context Replied, post #42 · Compounds › Semaglutide · 23 Jul 2025 · 5 likes Worth separating two things that post #38 runs together. Worth separating two things this subcategory keeps merging: what the molecule does, which is reasonably well…
Counter-ion content and its effect on measured mass Replied, post #96 · Analytics › Mass spectrometry · 19 Jul 2025 · 9 likes Mass accuracy is expressed in parts per million. It is the difference between observed and theoretical mass divided by theoretical mass, multiplied by a million. A…
A field-by-field walk through a certificate of analysis Replied, post #44 · Analytics › COA interpretation · 15 Jul 2025 · 0 likes Counterpoint on field-by-field walk through a certificate, offered without confidence: the same observation is consistent with a much duller explanation, and nobody has…
Substitution between formats during a shortage Replied, post #23 · Access › Shortages · 15 Jul 2025 · 7 likes Seconded. It reads as careful rather than confident, which is the right register.
Interim analyses and stopping rules — does this still hold? Replied, post #21 · Evidence › Trials · 30 Jun 2025 · 0 likes The estimand: what the trial set out to estimate. Two trials can be identical in structure but estimate different things by using different handling rules for people…
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #71 · Compounds › Retatrutide · 28 Jun 2025 · 0 likes Glucagon receptor agonism seems paradoxical in a weight-loss compound because glucagon raises blood glucose. The paradox resolves because glucagon agonism also…
Hepatic steatosis: what the MASH trial evidence supports Replied, post #71 · Clinical › Comorbidities · 21 Jun 2025 · 3 likes This follows post #70 rather than contradicting it. A definition problem is doing most of the work in this hepatic steatosis discussion. Once the term is pinned down I…
[2026 update] Dose numbers across compounds are not on the same scale Replied, post #18 · Practice › Dosing & titration · 16 Jun 2025 · 0 likes Building on post #15 rather than restating it. The starting dose in most of these programmes is a tolerance step and produces little effect by design. Judging the…
[2026 update] Citation sweep results: how many references did not say what was claimed Replied, post #36 · Meta › Wiki maintenance · 14 Jun 2025 · 18 likes Where I part company with post #34, and it is a narrow parting. That matches how I use it. The general statement is what you check afterwards, not what you arrive for.
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — what changed since Replied, post #89 · Practice › Reconstitution · 11 Jun 2025 · 1 like The useful distinction on 5 mg vial is between what was measured and what was inferred from it. Both end up in the same sentence and only one of them has error bars.
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #30 · Compounds › Cagrilintide & amylin analogues · 7 Jun 2025 · 30 likes On storage: aggregation-prone peptides are the ones where repeated warming and cooling does the most damage, and where a solution that looks fine may already have…
Coming back to: Getting a referral rather than a refusal Replied, post #32 · Clinical › Prescriber conversations · 4 Jun 2025 · 3 likes Prescription logistics: confirm whether it will be filled locally, requires mail order, or will be prescribed off-label and needs a compounding pharmacy. Different…
Reading a regulatory notice rather than an article about it — what changed since Replied, post #13 · Sourcing › Regulatory · 4 Jun 2025 · 25 likes Taking post #11 at face value and following it one step further. Regulatory approval is a decision about a specific product from a specific manufacturer. It does not…
Follow-up: What other technical communities get right that we do not Replied, post #113 · Lounge › Off topic · 29 May 2025 · 30 likes Lounge question, no agenda: does anyone else keep a physical notebook for this rather than a file? Mine is more use than anything I have typed, and I cannot entirely…
Second pass at: Semaglutide and alcohol: what is actually documented Replied, post #6 · Compounds › Semaglutide · 26 May 2025 · 1 like Picking up post #5: that is the part I would want checked first. Semaglutide and alcohol is one of those subjects where the general answer and the answer for a specific…
Journal club: STEP 4 and what a withdrawal design can prove Replied, post #44 · Evidence › Journal club · 23 May 2025 · 11 likes Post #40 put the caveat in the right place and I want to underline it. I would put moderate confidence on the mainstream reading of STEP 4 and no more. That is not…
Splitting a vial for two laboratories: how to do it without ruining both Replied, post #45 · Sourcing › Independent verification · 23 May 2025 · 0 likes I had read the opposite somewhere and cannot now find where, which tells me something.
Storing a pen in use versus a pen unopened Replied, post #13 · Devices › Pens & autoinjectors · 12 May 2025 · 23 likes Sensible. I would want the same detail before I acted on it either.
Why we hide unevidenced fraud accusations and log the hiding Replied, post #89 · Sourcing › Red flags · 2 May 2025 · 2 likes Prices well below the rest of the market are a fact rather than a finding. They are worth noting and they do not establish anything on their own. A partial answer,…
Retatrutide dose escalation in the published trials Replied, post #112 · Compounds › Retatrutide · 10 Apr 2025 · 21 likes Retatrutide is investigational. Anything obtained outside a trial is by definition research-use-only material with no human-use authorisation. This site will state that…
Adducts: sodium, potassium, and the peak you did not expect Replied, post #40 · Analytics › Mass spectrometry · 20 Mar 2025 · 19 likes Everything in post #39 holds. The case it does not cover is the one I have. Common adducts: sodium adds ≈22, potassium adds ≈38 compared to hydrogen. A [M+Na]+ peak is…
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #103 · Compounds › Semaglutide · 16 Mar 2025 · 1 like Post #99 put the caveat in the right place and I want to underline it. The most useful reply I ever got about published dose-response for semaglutide was a request to…
Pharmaceutical compounding rules, summarised from primary sources Replied, post #89 · Sourcing › Regulatory · 3 Mar 2025 · 20 likes Where I part company with post #85, and it is a narrow parting. Read the primary regulatory document rather than a summary of it. Summaries in this area lag by a year…
Pharmaceutical compounding rules, summarised from primary sources Replied, post #2 · Sourcing › Regulatory · 26 Feb 2025 · 0 likes The arithmetic in the opening post is right; the assumption feeding it is the part to check. On pharmaceutical compounding rules I would separate what is worth knowing…
When "no data" is the complete and final answer Replied, post #77 · Compounds › Other compounds · 28 Jan 2025 · 3 likes PT-141 was developed from the same family with a different receptor profile, and it has a considerably better documented human evidence base than most compounds…
[2026 update] Step therapy requirements and how to satisfy them Replied, post #121 · Access › Insurance & coverage · 14 Jan 2025 · 7 likes Offering a way to settle Step therapy requirements rather than another opinion about it. Two measurements, taken the same way, a fortnight apart. If the difference is…
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #133 · Compounds › Repair & healing peptides · 24 Nov 2024 · 1 like What would change the position on repair peptides: adequately powered, published, peer-reviewed randomised controlled human trials with pre-specified outcomes. That is…
Meeting a protein target on a suppressed appetite — does this still hold? Replied, post #14 · Nutrition & Training › Protein & intake · 21 Nov 2024 · 0 likes Adding a note of thanks rather than an opinion. I did not know most of that.
Coming back to: Preparing for an appointment: one page, three questions Replied, post #104 · Clinical › Prescriber conversations · 20 Nov 2024 · 0 likes Prescribers reading this subcategory consistently say the most difficult consultations are the ones where information is withheld rather than the ones with difficult…
Requesting a page: what makes a good request — what changed since Replied, post #45 · Documentation › Wiki requests · 10 Oct 2024 · 0 likes Where a request is for a translation or a regional version, the maintenance burden doubles and the proposal should say who carries it. The rule of thumb is fine; the…
Coming back to: The nausea timeline across the first four weeks, with a tabulated log Replied, post #16 · Practice › Side effects · 25 Sep 2024 · 31 likes Nausea: the most common side effect and the most dose- and titration-dependent one. It is usually most prominent in the first 24 to 48 hours after injection and…
The C-cell question: rodent findings and their human context — what changed since Replied, post #47 · Compounds › Semaglutide · 11 Sep 2024 · 7 likes On the injection-day question: the labelling for licensed semaglutide allows the day to be changed provided at least two days separate the two injections. That interval…
Second pass at: Sodium, potassium and magnesium when intake drops Replied, post #10 · Nutrition & Training › Hydration & electrolytes · 23 Jul 2024 · 21 likes Exercise and electrolyte losses: sweating during exercise increases sodium and potassium losses. Electrolyte replacement during or after intense exercise helps maintain…
Cold packs, phase-change material, and what survives ten days Replied, post #88 · Sourcing › Logistics · 10 Jul 2024 · 3 likes Anyone deciding whether a delay is a problem should ask what would change if they waited another week. Usually the answer is nothing. Adding the caveat now so it does…